Hans Biomed Overview
- Founded
- 1993
- Status
- Public
- Employees
- 274
- Stock Symbol
- 042520
- Investments
- 1
- Share Price
- $13.92
- (As of Tuesday Closing)
Hans Biomed General Information
Description
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.
Contact Information
Website
www.hansbiomed.com
Formerly Known As
Hans Medical
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
- 64, Yuseong-daero 1628 beon-gil
- Yuseong-gu
- Daejeon
- South Korea
+82 000-000-0000
Hans Biomed Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $13.92 | $14.07 | $9.56 - $23.65 | $139M | 10M | 115K | -$2.06 |
Hans Biomed Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2021 | FY 2020 30-Sep-2020 | FY 2019 30-Sep-2019 | FY 2018 30-Sep-2018 |
|---|---|---|---|---|
| EV | 131,058 | 211,751 | 192,978 | 281,497 |
| Revenue | 63,414 | 67,039 | 58,031 | 47,290 |
| EBITDA | (16,525) | (9,930) | 11,927 | 6,947 |
| Net Income | (20,343) | (14,932) | 8,620 | 3,801 |
| Total Assets | 127,541 | 112,669 | 111,383 | 82,668 |
| Total Debt | 47,194 | 28,077 | 27,907 | 10,813 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Hans Biomed Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Hans Biomed‘s full profile, request access.
Request a free trialHans Biomed Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Won-Gyun Kwon | Director & Head, Research |
Hans Biomed Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ke-Won Kang | Hans Biomed | Board Member and Chief of Research Center | 000 0000 |
| Kim Jin | Hans Biomed | Board Member | 000 0000 |
| Yong-Seok Cho | Hans Biomed | Board Member | 000 0000 |
Hans Biomed Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialHans Biomed Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Hans Biomed‘s full profile, request access.
Request a free trialHans Biomed Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 | 01-Jul-2019 | 00000 00000 00 | Therapeutic Devices |